| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |